跳至主要内容
临床试验/NCT04910139
NCT04910139已完成不适用

A User Study of the Soniflow System for Nasal Congestion Relief

Third Wave Therapeutics2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Total Nasal Symptom Score

研究概览

简要总结

The Soniflow System consists of an acoustic vibrational headband paired with a Smartphone App to provide rapid relief of nasal congestion.

详细描述

The Soniflow System is a non-invasive device to provide rapid relief of nasal congestion. It consists of a headband with ultrasound transducers (hardware) coupled to a Smartphone application (software).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is >18 years of age
  • Subject has had moderate to severe symptoms of nasal congestion for >3 months (TNSS rating of 2 or 3)
  • Subject has signed IRB-approved informed consent form

排除标准

  • Subject has neurologic comorbidities
  • Subject has active dental infection
  • Subject is pregnant
  • Subject has implanted intracranial electrostimulation device(s) (e.g. cochlear implant, deep brain stimulator)
  • Subject has undergone sinonasal or craniomaxillofacial surgery within the lats 3 months
  • Subject has been diagnosed with intracranial hemorrhage within the last 6 months
  • Subject has open scalp wounds or rashes
  • Subject has any history of craniotomy without replacement of a bone flap
  • Subject has elevated sensitivity to sound
  • Any physical condition that in the investigator's opinion would prevent adequate study participation or pose increased risk

结局指标

主要结局

Total Nasal Symptom Score

时间窗: 20 minutes

TNSS is a measure of nasal congestion, measured as the sum of four symptom scores for rhinorrhea, nasal congestion, nasal itching, and sneezing (using a scale of 0=None, 1=Mild, 2=Moderate, or 3=Severe). The minimum TNSS value is 0. The maximum TNSS value is 12. Lower TNSS score means a better outcome

次要结局

  • Visual Analog Scale (VAS) for Headache(20 minutes)
  • Visual Analog Scale (VAS) for Facial Pain(20 minutes)

研究者

发起方
Third Wave Therapeutics
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验